Your session is about to expire
← Back to Search
Clinical Data Collection and Evaluation of ECG-Less Cardiac CT
N/A
Waitlist Available
Research Sponsored by GE Healthcare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 months
Awards & highlights
No Placebo-Only Group
Summary
The primary objective of this study is to collect CT scan data without ECG-leads attached to the human subject. This data is intended to represent a typical range of clinical scenarios in which Cardiac CT imaging is used.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Data Collection
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: ECG-Less Cardiac CTExperimental Treatment1 Intervention
Enrolled subjects will receive a clinically-indicated, diagnostic Cardiac CT with contrast. No ECG leads will be applied.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ECG-Less Cardiac CT using SmartPhase
2023
N/A
~60
Find a Location
Who is running the clinical trial?
GE HealthcareLead Sponsor
303 Previous Clinical Trials
633,899 Total Patients Enrolled
University of ChicagoOTHER
1,059 Previous Clinical Trials
839,697 Total Patients Enrolled
University of WashingtonOTHER
1,827 Previous Clinical Trials
1,906,758 Total Patients Enrolled
Kayla MatcheckStudy DirectorGE Healthcare